Filament Health posts $5M loss in 2024, faces liquidity concerns
The clinical-stage natural psychedelic company showed progress in its drug development pipeline while dealing with a shrinking runway.
The post Filament Health posts $5M loss in 2024, faces liquidity concerns appeared first on Green Market Report.
